Syn X Faces Dire Financial Future; Estimates $2.1M Deficit for 2003
Despite record revenues last year, Syn X Pharma of Toronto is facing a gloomy financial future.
Syn X Faces Dire Financial Future; Estimates $2.1M Deficit for 2003
Despite record revenues last year, Syn X Pharma of Toronto is facing a gloomy financial future.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.